Sirolimus for the Treatment of Vascular Anomalies
Joana M. Mack(University of Arkansas for Medical Sciences), Kiersten Ricci(Cincinnati Children's Hospital Medical Center), Denise M. Adams(Children's Hospital of Philadelphia)
Cited by 1
Related Papers
Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham–Stout disease
|Pediatric Blood & Cancer|2019|126
Vascular Anomalies
|Hematology/Oncology Clinics of North America|2019|122
Kaposiform lymphangiomatosis effectively treated with MEK inhibition
|EMBO Molecular Medicine|2020|104
Genomic profiling informs diagnoses and treatment in vascular anomalies
|Nature Medicine|2023|63
How we approach the diagnosis and management of complex lymphatic anomalies
|Pediatric Blood & Cancer|2021|52